Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

HOPA 2018 | The challenges of modern day immunotherapy for pharmacists

Jacob Kettle • 21 Mar 2018
HOPA 2018
General

Here, Jacob Kettle, PharmD, BCOP, of the University of Missouri Health Care, Columbia, MO, shares his perspective on the different challenges surrounding the advancements made in the development of newer immunotherapy agents for pharmacists, including the need to constantly keep up to date with newly approved drugs, and being aware of their side effects on different organ systems upon administration. This video was recorded at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference held in Denver, CO.

More from Jacob Kettle

1:24
How can pharmacists approach the ‘grey area’ surrounding PD-L1 testing?
Jacob Kettle • 21 Mar 2018
3:22
Drugs with low response rates - should they always be offered to patients?
Jacob Kettle • 21 Mar 2018
3:50
The role of PD-L1: is it accurate enough as a biomarker for immunotherapy response?
Jacob Kettle • 21 Mar 2018

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals